Key Takeaways
- Sequential growth despite softness: Revenue grew sequentially for the third straight quarter, with barium delivering exponential volume growth after a U.S. peer mothballed production, creating a value-accretive share gain.
- Barium profitability is structural, not one-off: Barium sulfate utilization crossed 70% in Q3, up from 60–70% earlier, and management expects 80–85% in FY26; the ramp follows a long customer-approval cycle after the August 2023 plant startup, so the EBITDA lift is durable.
- Backward integration is the strategic backbone: The Ramdas Minerals acquisition has already recouped ~40% of its cost in five quarters, and definitive agreements for a South Africa chrome-ore mine (reserves for 25–30 years) have been signed, with operations starting one to two quarters after approvals.
- New products are coming fast: Strontium carbonate (via Jayansree Pharma acquisition) commissions in Q1 FY26, and chrome metal production starts toward Q3 FY26; both are import-replacement plays in growing Indian end-markets.
- What to watch next quarter: The pace of government clearances for the South Africa mine, the commissioning of strontium carbonate, and whether barium utilization continues its climb toward the 80–85% target.
Barium: The Volume & Margin Inflection
- U.S. competitor exit unlocked a structural share gain: A peer mothballed production, allowing Vishnu to capture majority share in the U.S. market; management describes the win as value-accretive with customer stickiness, not a transient fill-in.
- Utilization is climbing fast: Barium chemicals utilization exceeded 70% in Q3, up from the 60–70% range across the first nine months; management is confident of reaching 80–85% in FY26, which will further improve operating leverage.
- Profitability ramp is a lagged effect of the August 2023 plant startup: Customer approvals and the journey to optimal operating levels took time; now both barium carbonate and barium sulfate are running at much higher operating levels, and the EBITDA lift is expected to persist.
- China is not a threat in barium: Management explicitly stated China is not competition in the barium business now, citing significant U.S. duties on Chinese product and the cost advantage from backward integration via Ramdas Minerals.
- Volume growth target: At least 15–20% volume growth expected next year, which will further improve operating leverage.
Siddartha Cherukuri: "It's not a one-off thing. Reason being we have done this capex and the barium sulfate has become operational during August 2023. So we have taken some time for customer approval, getting to the optimal operating level."
Backward Integration: Ramdas Minerals & South Africa Mine
- Ramdas Minerals payback is ahead of plan: Nearly 40% of the INR26 crore acquisition cost has been recouped in about five quarters since July 2023; the target is full payback within 2.5 years of investment.
- South Africa chrome-ore mine signed: Definitive agreements are in place for a mine containing close to 1 crore tons of chrome ore, sufficient for 25–30 years of requirement; the company is now seeking approvals and statutory clearances.
- Operations can start quickly after approvals: Once clearances are in place, mining operations can begin within one to two quarters; management declined to provide an exact timeline due to the sensitivity of pending government approvals.
- Margin accretion is promised but unquantified: The mine will be margin-accretive and provide long-term raw material security, but management refused to share the exact quantum of EBITDA increase until clearances are in hand.
Hanumant Bhansali: "This is a mine that is owned by a multinational, and it contains reserves to the extent of close to 1 crore tons of chrome ore, which can suffice our requirement for at least 30 years as per our estimates."
New Products: Strontium Carbonate & Chrome Metal
- Strontium carbonate enters the portfolio via acquisition: Vishnu acquired Jayansree Pharma, whose Visakhapatnam plant sits close to the existing Parawada facility; the plant will be commissioned within one quarter of acquisition, in Q1 FY26.
- The acquisition economics are compelling: Management estimates a greenfield build would have cost ~INR120 crores and taken four quarters; the acquired plant delivers the same capacity at a fraction of the time and cost.
- Import-substitution opportunity: Strontium carbonate is used in electric motors, automobiles, zinc electrolysis plants, and ceramics; top exporters to India are Mexico, Belgium, and Spain.
- Chrome metal production starts toward Q3 FY26: This is an import-replacement product with sizable Indian consumption in defense, welding, and super alloys; it uses more of the company's own feedstock and will be value-accretive.
- Chrome metal EBITDA impact: The addition will help EBITDA margins in H2 FY26.
Siddartha Cherukuri: "It's an import replacement product. I mean, there's a sizable consumption in India as well, and it's going to grow in the years to come given the fact that the defense as well as the welding business in the super alloys sector is growing."
Chromium: Utilization, Margins & Capacity Expansion
- Current utilization is strong: Operating at over 70,000 tons out of 82,000 tons total capacity.
- Gross margin reached ~43% in 9M FY25: Driven by price increases in chromium chemicals to pass on raw material and freight cost increases, plus a higher contribution from value-added derivatives like chromic acid and chrome oxide green.
- Capacity expansion is downstream-focused: An additional 10,000–12,000 tons of capacity for chrome oxide and chrome metal is planned during FY27; management declined to bifurcate the split between the two products.
- Land is available for future projects: Nearly 40–50 acres of space is available at the Srikalahasti site.
Logistics, Diversification & Balance Sheet
- Freight costs have normalised to workable levels: Sea freights had risen fourfold but have since come off, though not to pre-Red Sea levels; the company is able to pass freight increases to customers.
- Israel-Palestine truce could improve logistics further: Management has a positive outlook on logistics costs, expecting further gross margin improvement in both barium and chromium if the truce holds.
- Market mix is better balanced: Europe exposure has been reduced from 40–45% to 30%, while the U.S. now accounts for 25%; customer wins have been added in both regions over the last year.
- Credit rating upgraded to CARE A-: The upgrade applies to long-term facilities.
- CCPS conversion strengthens the balance sheet: The board approved allotment of 17,88,089 equity shares to promoters at ₹428.6 per share; long-term borrowings will decrease by ~₹76 crores by the end of the current financial year.
- SAP migration completed: The company successfully migrated to SAP, improving real-time data access and decision-making across all locations.
Siddartha Cherukuri: "And with what's happening with the truce between Israel and Palestine, probably it can get even better in the coming quarter or so. So we are having a quite positive outlook on our logistics cost, which is going to further improve our gross margins, both in barium and chromium."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | 15–20% revenue growth | FY26 |
| Barium volume growth | At least 15–20% volume growth | FY26 |
| Barium capacity utilization | Reach 80–85% utilization | FY26 |
| Strontium carbonate commissioning | Plant operational | Q1 FY26 |
| Chrome metal production start | Production begins | Q3 FY26 |
| Chrome metal EBITDA impact | Helps EBITDA margins | H2 FY26 |
| Chrome oxide and chrome metal capacity expansion | Additional 10,000–12,000 tons capacity | FY27 |
| South Africa mine operations start | Operations begin within one to two quarters of receiving approvals | Undated (pending government clearances) |
| Ramdas Minerals full payback | Full investment recouped | Within 2.5 years from July 2023 acquisition |
| CCPS conversion & debt reduction | Long-term borrowings decrease by ~₹76 crores | By end of current financial year |
Key Metrics
| Metric | Q3 FY25 |
|---|---|
| Consolidated operating revenue | ₹371 cr, +22% YoY |
| Consolidated EBITDA | ₹63 cr, +55% YoY |
| Consolidated PAT | ₹34 cr, +66% YoY |
| Consolidated EBITDA margin | 17% |
| Consolidated PAT margin | 9.3% |
| 9M FY25 consolidated operating revenue | ₹1,053 cr, +15% YoY |
| 9M FY25 consolidated EBITDA | ₹164 cr, +19% YoY |
| 9M FY25 consolidated PAT | ₹87 cr, +20% YoY |
| 9M FY25 consolidated EBITDA margin | 15.6% |
| 9M FY25 consolidated PAT margin | 8.3% |
| Chromium chemicals capacity utilization | ~70,000 tons out of 82,000 tons capacity |
| Barium chemicals capacity utilization | In excess of 70% in Q3, up from 60–70% in 9M FY25 |
| Barium segment volume growth outlook | 15% to 20% expected for FY26 |
| Chromium chemicals gross margin (9M FY25) | ~43% |
| Barium domestic market share | 65–70% |
| Long-term borrowings reduction from CCPS conversion | ~₹76 cr expected by end of FY25 |